Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Proteome | 5 | 2022 | 34 | 1.730 |
Why?
|
Proteomics | 5 | 2018 | 92 | 1.670 |
Why?
|
Ginsenosides | 5 | 2012 | 5 | 1.300 |
Why?
|
Panax | 5 | 2011 | 8 | 1.220 |
Why?
|
Platelet Aggregation Inhibitors | 3 | 2012 | 85 | 0.790 |
Why?
|
Platelet Aggregation | 3 | 2012 | 21 | 0.740 |
Why?
|
Antineoplastic Agents | 3 | 2014 | 548 | 0.690 |
Why?
|
Neuromyelitis Optica | 1 | 2016 | 1 | 0.570 |
Why?
|
Cerebrospinal Fluid | 1 | 2016 | 13 | 0.570 |
Why?
|
Neoplasm Proteins | 2 | 2014 | 141 | 0.560 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2014 | 252 | 0.540 |
Why?
|
Exosomes | 1 | 2016 | 39 | 0.540 |
Why?
|
Multiple Sclerosis | 1 | 2016 | 43 | 0.540 |
Why?
|
Macaca mulatta | 2 | 2022 | 323 | 0.510 |
Why?
|
Pancreatic Neoplasms | 2 | 2013 | 133 | 0.510 |
Why?
|
Histones | 1 | 2014 | 49 | 0.490 |
Why?
|
Plant Roots | 2 | 2011 | 3 | 0.480 |
Why?
|
Protein Kinase Inhibitors | 1 | 2013 | 80 | 0.450 |
Why?
|
Alzheimer Disease | 3 | 2022 | 313 | 0.450 |
Why?
|
Colorectal Neoplasms | 1 | 2014 | 208 | 0.420 |
Why?
|
Adenocarcinoma | 1 | 2014 | 302 | 0.400 |
Why?
|
Complement Inactivating Agents | 1 | 2011 | 2 | 0.390 |
Why?
|
Complement Pathway, Classical | 1 | 2011 | 2 | 0.390 |
Why?
|
AMP-Activated Protein Kinases | 2 | 2021 | 20 | 0.380 |
Why?
|
Animals | 15 | 2022 | 7339 | 0.370 |
Why?
|
Cell Line, Tumor | 6 | 2021 | 692 | 0.310 |
Why?
|
Humans | 20 | 2022 | 29552 | 0.290 |
Why?
|
Plant Extracts | 4 | 2011 | 60 | 0.280 |
Why?
|
Drug Screening Assays, Antitumor | 3 | 2014 | 50 | 0.260 |
Why?
|
Tandem Mass Spectrometry | 3 | 2015 | 57 | 0.260 |
Why?
|
Mice | 7 | 2022 | 2387 | 0.260 |
Why?
|
Male | 12 | 2022 | 18012 | 0.260 |
Why?
|
Mass Spectrometry | 4 | 2022 | 100 | 0.260 |
Why?
|
Rats | 4 | 2015 | 1609 | 0.250 |
Why?
|
Oxidation-Reduction | 3 | 2022 | 251 | 0.240 |
Why?
|
Female | 12 | 2022 | 18379 | 0.230 |
Why?
|
Pyrimidines | 2 | 2013 | 60 | 0.220 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2022 | 10 | 0.210 |
Why?
|
Receptor, EphA4 | 1 | 2022 | 1 | 0.210 |
Why?
|
Sulfhydryl Compounds | 1 | 2022 | 33 | 0.210 |
Why?
|
MAP Kinase Signaling System | 1 | 2021 | 57 | 0.200 |
Why?
|
Multiple Myeloma | 1 | 2021 | 15 | 0.190 |
Why?
|
Apoptosis | 3 | 2019 | 352 | 0.190 |
Why?
|
Melanoma | 1 | 2022 | 148 | 0.180 |
Why?
|
Chromatography, High Pressure Liquid | 5 | 2013 | 93 | 0.180 |
Why?
|
15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid | 2 | 2010 | 5 | 0.180 |
Why?
|
Diet, Reducing | 1 | 2020 | 90 | 0.180 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2020 | 83 | 0.180 |
Why?
|
Rats, Sprague-Dawley | 3 | 2012 | 748 | 0.170 |
Why?
|
Stearoyl-CoA Desaturase | 1 | 2019 | 14 | 0.170 |
Why?
|
Vasoconstrictor Agents | 2 | 2010 | 62 | 0.170 |
Why?
|
Hindlimb Suspension | 1 | 2019 | 11 | 0.170 |
Why?
|
Adiposity | 1 | 2020 | 192 | 0.170 |
Why?
|
Space Flight | 1 | 2019 | 19 | 0.170 |
Why?
|
Collagen | 2 | 2010 | 218 | 0.160 |
Why?
|
Cocaine | 1 | 2022 | 266 | 0.160 |
Why?
|
Ovarian Neoplasms | 1 | 2019 | 88 | 0.160 |
Why?
|
Cartilage, Articular | 1 | 2019 | 72 | 0.160 |
Why?
|
Hip Joint | 1 | 2019 | 57 | 0.160 |
Why?
|
Flow Cytometry | 2 | 2016 | 173 | 0.160 |
Why?
|
Chromatography, Liquid | 2 | 2015 | 42 | 0.160 |
Why?
|
Knee Joint | 1 | 2019 | 129 | 0.150 |
Why?
|
Adipose Tissue | 1 | 2020 | 332 | 0.150 |
Why?
|
Weight Loss | 1 | 2020 | 416 | 0.150 |
Why?
|
Muscle Denervation | 1 | 2017 | 28 | 0.150 |
Why?
|
Peroxiredoxins | 1 | 2018 | 106 | 0.150 |
Why?
|
Muscle Fibers, Fast-Twitch | 1 | 2017 | 29 | 0.150 |
Why?
|
Oxidative Stress | 1 | 2019 | 224 | 0.150 |
Why?
|
Spectrometry, Mass, Electrospray Ionization | 2 | 2013 | 34 | 0.140 |
Why?
|
Glial Fibrillary Acidic Protein | 1 | 2016 | 37 | 0.140 |
Why?
|
Fibronectins | 1 | 2016 | 34 | 0.140 |
Why?
|
Troponin T | 1 | 2017 | 64 | 0.140 |
Why?
|
Protoporphyria, Erythropoietic | 1 | 2015 | 10 | 0.130 |
Why?
|
Sequence Analysis, Protein | 1 | 2015 | 4 | 0.130 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2018 | 179 | 0.130 |
Why?
|
Databases, Protein | 1 | 2015 | 13 | 0.130 |
Why?
|
Cattle | 1 | 2015 | 100 | 0.130 |
Why?
|
Iron | 1 | 2015 | 113 | 0.120 |
Why?
|
Software | 1 | 2015 | 110 | 0.120 |
Why?
|
Phosphorylation | 3 | 2022 | 228 | 0.120 |
Why?
|
Drug Synergism | 1 | 2013 | 69 | 0.120 |
Why?
|
Thiazoles | 1 | 2013 | 32 | 0.120 |
Why?
|
Cell Movement | 1 | 2014 | 161 | 0.120 |
Why?
|
Neoplasm Metastasis | 1 | 2014 | 199 | 0.120 |
Why?
|
Heme Oxygenase-1 | 1 | 2013 | 33 | 0.120 |
Why?
|
Benzamides | 1 | 2013 | 54 | 0.110 |
Why?
|
Piperazines | 1 | 2013 | 56 | 0.110 |
Why?
|
Indoles | 1 | 2013 | 59 | 0.110 |
Why?
|
Arachidonic Acid | 2 | 2012 | 35 | 0.110 |
Why?
|
Mebendazole | 1 | 2013 | 1 | 0.110 |
Why?
|
Sulfanilamides | 1 | 2013 | 1 | 0.110 |
Why?
|
Veterinary Drugs | 1 | 2013 | 1 | 0.110 |
Why?
|
Food Analysis | 1 | 2013 | 3 | 0.110 |
Why?
|
Pyrroles | 1 | 2013 | 55 | 0.110 |
Why?
|
Porphyria, Acute Intermittent | 1 | 2013 | 13 | 0.110 |
Why?
|
Brain | 1 | 2020 | 933 | 0.110 |
Why?
|
Circadian Rhythm | 1 | 2013 | 43 | 0.110 |
Why?
|
Cell Survival | 1 | 2013 | 278 | 0.110 |
Why?
|
12-Hydroxy-5,8,10,14-eicosatetraenoic Acid | 1 | 2012 | 1 | 0.110 |
Why?
|
Blood Platelets | 1 | 2012 | 38 | 0.110 |
Why?
|
Metabolome | 1 | 2012 | 31 | 0.110 |
Why?
|
Food Inspection | 1 | 2012 | 1 | 0.100 |
Why?
|
Food Contamination | 1 | 2012 | 2 | 0.100 |
Why?
|
Appetite Depressants | 1 | 2012 | 6 | 0.100 |
Why?
|
Algorithms | 1 | 2015 | 468 | 0.100 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2012 | 643 | 0.100 |
Why?
|
Iris Plant | 1 | 2011 | 1 | 0.100 |
Why?
|
Complement Fixation Tests | 1 | 2011 | 1 | 0.100 |
Why?
|
Chemical Fractionation | 1 | 2011 | 2 | 0.100 |
Why?
|
Osmolar Concentration | 1 | 2011 | 19 | 0.100 |
Why?
|
Liver Neoplasms | 1 | 2012 | 163 | 0.090 |
Why?
|
Rotavirus | 1 | 2010 | 4 | 0.090 |
Why?
|
Erythrocytes | 1 | 2011 | 45 | 0.090 |
Why?
|
Adenosine Diphosphate | 1 | 2010 | 5 | 0.090 |
Why?
|
Polysaccharides | 1 | 2010 | 13 | 0.090 |
Why?
|
Acetylation | 1 | 2010 | 13 | 0.090 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2011 | 78 | 0.090 |
Why?
|
Spectrophotometry, Ultraviolet | 1 | 2010 | 18 | 0.090 |
Why?
|
Dietary Supplements | 1 | 2012 | 172 | 0.090 |
Why?
|
Aging | 1 | 2017 | 891 | 0.090 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2011 | 71 | 0.090 |
Why?
|
Sheep | 1 | 2011 | 224 | 0.090 |
Why?
|
Antiviral Agents | 1 | 2010 | 101 | 0.090 |
Why?
|
Betula | 1 | 2008 | 1 | 0.080 |
Why?
|
Plant Proteins | 1 | 2008 | 13 | 0.080 |
Why?
|
Triterpenes | 1 | 2008 | 4 | 0.080 |
Why?
|
Adult | 3 | 2016 | 8528 | 0.080 |
Why?
|
Phytotherapy | 1 | 2008 | 38 | 0.080 |
Why?
|
Hydroxyl Radical | 1 | 2008 | 3 | 0.080 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 2008 | 38 | 0.080 |
Why?
|
Middle Aged | 3 | 2016 | 10936 | 0.080 |
Why?
|
Disease Models, Animal | 2 | 2021 | 984 | 0.070 |
Why?
|
Metabolomics | 2 | 2020 | 46 | 0.070 |
Why?
|
Age Factors | 2 | 2020 | 1120 | 0.070 |
Why?
|
Lung Neoplasms | 1 | 2008 | 389 | 0.060 |
Why?
|
Breast Neoplasms | 1 | 2011 | 680 | 0.060 |
Why?
|
Limit of Detection | 2 | 2013 | 15 | 0.050 |
Why?
|
Aged, 80 and over | 2 | 2020 | 3764 | 0.050 |
Why?
|
GMP Reductase | 1 | 2022 | 1 | 0.050 |
Why?
|
Guanosine Triphosphate | 1 | 2022 | 8 | 0.050 |
Why?
|
Nucleotides | 1 | 2022 | 16 | 0.050 |
Why?
|
Peptide Elongation Factor 2 | 1 | 2022 | 3 | 0.050 |
Why?
|
Elongation Factor 2 Kinase | 1 | 2022 | 3 | 0.050 |
Why?
|
Case-Control Studies | 2 | 2015 | 861 | 0.050 |
Why?
|
Kinetics | 1 | 2022 | 206 | 0.050 |
Why?
|
Syndrome | 1 | 2022 | 66 | 0.050 |
Why?
|
Cerebral Amyloid Angiopathy | 1 | 2021 | 3 | 0.050 |
Why?
|
Brain Chemistry | 1 | 2021 | 30 | 0.050 |
Why?
|
Computational Biology | 1 | 2021 | 86 | 0.050 |
Why?
|
Carbohydrate Metabolism | 1 | 2020 | 13 | 0.050 |
Why?
|
Amino Acids | 1 | 2020 | 41 | 0.050 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2021 | 92 | 0.050 |
Why?
|
Isoenzymes | 1 | 2020 | 64 | 0.050 |
Why?
|
Hippocampus | 1 | 2021 | 185 | 0.040 |
Why?
|
Mutation | 1 | 2022 | 475 | 0.040 |
Why?
|
Mice, Transgenic | 1 | 2020 | 249 | 0.040 |
Why?
|
Behavior, Animal | 1 | 2021 | 264 | 0.040 |
Why?
|
Aged | 3 | 2020 | 9590 | 0.040 |
Why?
|
Cell Death | 1 | 2019 | 74 | 0.040 |
Why?
|
X-Ray Microtomography | 1 | 2019 | 40 | 0.040 |
Why?
|
Dose-Response Relationship, Radiation | 1 | 2019 | 76 | 0.040 |
Why?
|
Pregnancy | 1 | 2022 | 825 | 0.040 |
Why?
|
Oxidants | 1 | 2019 | 15 | 0.040 |
Why?
|
Amino Acid Motifs | 1 | 2018 | 23 | 0.040 |
Why?
|
Crystallography, X-Ray | 1 | 2018 | 77 | 0.040 |
Why?
|
Peptide Fragments | 1 | 2021 | 423 | 0.040 |
Why?
|
Antioxidants | 1 | 2019 | 114 | 0.040 |
Why?
|
Hydrogen Peroxide | 1 | 2018 | 82 | 0.040 |
Why?
|
Models, Molecular | 1 | 2018 | 178 | 0.040 |
Why?
|
Amino Acid Sequence | 1 | 2018 | 283 | 0.040 |
Why?
|
Cyclic AMP-Dependent Protein Kinase RIIalpha Subunit | 1 | 2017 | 8 | 0.040 |
Why?
|
Cysteine | 1 | 2018 | 131 | 0.040 |
Why?
|
Fluorescent Antibody Technique | 1 | 2017 | 85 | 0.040 |
Why?
|
Neuromuscular Junction | 1 | 2017 | 67 | 0.040 |
Why?
|
Mice, Inbred C57BL | 1 | 2019 | 713 | 0.040 |
Why?
|
Muscle Contraction | 1 | 2017 | 114 | 0.040 |
Why?
|
Action Potentials | 1 | 2017 | 175 | 0.030 |
Why?
|
Synaptic Transmission | 1 | 2017 | 115 | 0.030 |
Why?
|
Erythropoietin | 1 | 2015 | 29 | 0.030 |
Why?
|
Ferritins | 1 | 2015 | 46 | 0.030 |
Why?
|
Homeostasis | 1 | 2015 | 127 | 0.030 |
Why?
|
Gene Expression Regulation | 1 | 2017 | 484 | 0.030 |
Why?
|
Cytokines | 1 | 2015 | 243 | 0.030 |
Why?
|
Time Factors | 1 | 2019 | 2014 | 0.030 |
Why?
|
Melatonin | 1 | 2013 | 2 | 0.030 |
Why?
|
Porphobilinogen | 1 | 2013 | 8 | 0.030 |
Why?
|
5-Aminolevulinate Synthetase | 1 | 2013 | 26 | 0.030 |
Why?
|
Hydrocortisone | 1 | 2013 | 61 | 0.030 |
Why?
|
Heme | 1 | 2013 | 60 | 0.030 |
Why?
|
Thromboxane B2 | 1 | 2012 | 6 | 0.030 |
Why?
|
Vimentin | 1 | 2012 | 9 | 0.030 |
Why?
|
Subcellular Fractions | 1 | 2012 | 14 | 0.030 |
Why?
|
Cyclooxygenase 1 | 1 | 2012 | 23 | 0.030 |
Why?
|
Principal Component Analysis | 1 | 2012 | 60 | 0.030 |
Why?
|
Protein Transport | 1 | 2012 | 75 | 0.030 |
Why?
|
Cyclooxygenase Inhibitors | 1 | 2012 | 39 | 0.030 |
Why?
|
Cyclooxygenase 2 | 1 | 2012 | 50 | 0.030 |
Why?
|
Cyclobutanes | 1 | 2012 | 2 | 0.030 |
Why?
|
Photometry | 1 | 2012 | 3 | 0.030 |
Why?
|
Republic of Korea | 1 | 2012 | 8 | 0.030 |
Why?
|
Aspirin | 1 | 2012 | 66 | 0.030 |
Why?
|
Anti-Obesity Agents | 1 | 2012 | 6 | 0.030 |
Why?
|
Carbolines | 1 | 2012 | 9 | 0.030 |
Why?
|
Androgens | 1 | 2012 | 25 | 0.030 |
Why?
|
Electrochemical Techniques | 1 | 2012 | 22 | 0.030 |
Why?
|
Blotting, Western | 1 | 2012 | 286 | 0.030 |
Why?
|
Pilot Projects | 1 | 2013 | 489 | 0.020 |
Why?
|
Proteins | 1 | 2012 | 141 | 0.020 |
Why?
|
Guideline Adherence | 1 | 2012 | 111 | 0.020 |
Why?
|
RNA, Messenger | 1 | 2013 | 523 | 0.020 |
Why?
|
Caspase 7 | 1 | 2011 | 3 | 0.020 |
Why?
|
bcl-2-Associated X Protein | 1 | 2011 | 14 | 0.020 |
Why?
|
Gene Expression Profiling | 1 | 2012 | 321 | 0.020 |
Why?
|
Membrane Proteins | 1 | 2012 | 257 | 0.020 |
Why?
|
Internet | 1 | 2012 | 158 | 0.020 |
Why?
|
Multivariate Analysis | 1 | 2012 | 638 | 0.020 |
Why?
|
Chromatography, Ion Exchange | 1 | 2010 | 4 | 0.020 |
Why?
|
Molecular Weight | 1 | 2010 | 42 | 0.020 |
Why?
|
Calcium | 1 | 2012 | 302 | 0.020 |
Why?
|
Hypoglycemic Agents | 1 | 2012 | 177 | 0.020 |
Why?
|
Microbial Sensitivity Tests | 1 | 2010 | 55 | 0.020 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2010 | 81 | 0.020 |
Why?
|
Disease Progression | 1 | 2012 | 574 | 0.020 |
Why?
|
Cell Line | 1 | 2010 | 456 | 0.020 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 2008 | 37 | 0.020 |
Why?
|
Maillard Reaction | 1 | 2008 | 1 | 0.020 |
Why?
|
Chemistry, Pharmaceutical | 1 | 2008 | 11 | 0.020 |
Why?
|
Electron Spin Resonance Spectroscopy | 1 | 2008 | 10 | 0.020 |
Why?
|
Cisplatin | 1 | 2008 | 70 | 0.020 |
Why?
|
Models, Chemical | 1 | 2008 | 30 | 0.020 |
Why?
|
Superoxides | 1 | 2008 | 17 | 0.020 |
Why?
|
Glycine | 1 | 2008 | 25 | 0.020 |
Why?
|
Free Radical Scavengers | 1 | 2008 | 11 | 0.020 |
Why?
|
Light | 1 | 2008 | 25 | 0.020 |
Why?
|
Ethanol | 1 | 2011 | 186 | 0.020 |
Why?
|
Hot Temperature | 1 | 2008 | 74 | 0.020 |
Why?
|
Glucose | 1 | 2008 | 165 | 0.020 |
Why?
|